SWM
CORT icon

SHP Wealth Management’s Corcept Therapeutics CORT Stock Holding History

SHP Wealth Management’s Portfolio CORT Stock Details CORT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$79.7K Sell
1,976
-94
-5% -$3.52K 0.01% 421
2025
Q4 		$72K Buy
+2,070
New +$163K 0.01% 409

Other funds holding CORT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ISL
Ingalls & Snyder LLC New York $2.83B AUM 21.61% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
PA
Parallel Advisors San Francisco, California $6.56B AUM 32.24% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return

SHP Wealth Management's CORT Position: Q1 2026 in Review

SHP Wealth Management reduced its Corcept Therapeutics (CORT) stake by 4.5% in Q1 2026, selling an estimated $3.52K and leaving 1,976 shares worth $79.7K. The position accounts for 0.01% of the portfolio, ranked #421.

SHP Wealth Management first reported a position in CORT in Q4 2025 and has held it in 2 quarters since. 351 funds tracked by Wall St. Rank hold CORT as of Q1 2026.

  • SHP Wealth Management held 1,976 shares of Corcept Therapeutics worth $79.7K as of Q1 2026.
  • SHP Wealth Management sold 94 Corcept Therapeutics shares in Q1 2026, an estimated $3.52K.
  • Corcept Therapeutics made up 0.01% of SHP Wealth Management's portfolio in Q1 2026, its #421 holding.
  • SHP Wealth Management first reported a position in Corcept Therapeutics in Q4 2025 and has held it in 2 quarters since.
  • 351 funds tracked by Wall St. Rank held Corcept Therapeutics as of Q1 2026.

Based on SHP Wealth Management's 13F filing for Q1 2026, filed 8 May 2026.